{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:13:33Z","timestamp":1740107613400,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24592018"],"award-info":[{"award-number":["24592018"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00595-019-01842-5","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T14:06:31Z","timestamp":1562076391000},"page":"1035-1043","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Collagen gel droplet-embedded culture drug sensitivity test (CD-DST) predicts the effect of adjuvant chemotherapy on pancreatic cancer"],"prefix":"10.1007","volume":"49","author":[{"given":"Kyohei","family":"Ariake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuyuhiko","family":"Motoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamichi","family":"Mizuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Hata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsutaka","family":"Mitachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Naitoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiaki","family":"Unno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,2]]},"reference":[{"key":"1842_CR1","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/SLA.0000000000002234","volume":"267","author":"VP Groot","year":"2018","unstructured":"Groot VP, Rezaee N, Wu W, Cameron JL, Fishman EK, Hruban RH, et al. Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma. Ann Surg. 2018;267:936\u201345.","journal-title":"Ann Surg."},{"key":"1842_CR2","unstructured":"National Comprehensive Cancer Network. NCCN guidelines version.018 pancreatic adenocarcinoma. \n                    https:\/\/www.nccn.org\/store\/login\/login.aspx?ReturnURL=https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/pancreatic.pdf\n                    \n                  ."},{"key":"1842_CR3","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/sj.bjc.6604528","volume":"99","author":"CW Michalski","year":"2008","unstructured":"Michalski CW, Erkan M, Sauliunaite D, Giese T, Stratmann R, Sartori C, et al. Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer. Br J Cancer. 2008;99:760\u20137.","journal-title":"Br J Cancer"},{"key":"1842_CR4","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s10120-015-0506-z","volume":"19","author":"N Tanigawa","year":"2016","unstructured":"Tanigawa N, Yamaue H, Ohyama S, Sakuramoto S, Inada T, Kodera Y, et al. Exploratory phase ii trial in a multicenter setting to evaluate the clinical value of a chemosensitivity test in patients with gastric cancer (JACCRO-GC 04, Kubota memorial trial). Gastric Cancer. 2016;19:350\u201360.","journal-title":"Gastric Cancer"},{"key":"1842_CR5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3892\/mco.2013.102","volume":"1","author":"E Mekata","year":"2013","unstructured":"Mekata E, Sonoda H, Shimizu T, Tatsuta T, Yamaguchi T, Endo Y, et al. Clinical predictive value of in vitro anticancer drug sensitivity test for the therapeutic effect of adjuvant chemotherapy in patients with stages II\u2013III colorectal cancer. Mol Clin Oncol. 2013;1:763\u20137.","journal-title":"Mol Clin Oncol"},{"key":"1842_CR6","first-page":"449","volume":"11","author":"H Kobayashi","year":"1997","unstructured":"Kobayashi H, Tanisaka K, Doi O, Kodama K, Higashiyama M, Nakagawa H, et al. An in vitro chemosensitivity test for solid human tumors using collagen gel droplet embedded cultures. Int J Oncol. 1997;11:449\u201355.","journal-title":"Int J Oncol"},{"key":"1842_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s005340050044","volume":"5","author":"H Yasuda","year":"1998","unstructured":"Yasuda H, Takada T, Wada K, Amano H, Isaka T, Yoshida M, et al. A new in-vitro drug sensitivity test (collagen-gel droplet embedded-culture drug sensitivity test) in carcinomas of pancreas and biliary tract: possible clinical utility. J Hepatobiliary Pancreat Surg. 1998;5:261\u20138.","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"1842_CR8","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature12626","volume":"501","author":"MR Junttila","year":"2013","unstructured":"Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013;501:346\u201354.","journal-title":"Nature"},{"key":"1842_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10120-010-0564-1","volume":"13","author":"K Maejima","year":"2010","unstructured":"Maejima K, Tokunaga A, Kiyama T, Kanno H, Bou H, Watanabe M, et al. Chemosensitivity test for 5-fluorouracil and 5-chloro-2,4-dihydroxypyridine predicts outcome of gastric cancer patients receiving s-1 postoperatively. Gastric Cancer. 2010;13:231\u20137.","journal-title":"Gastric Cancer"},{"key":"1842_CR10","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s10120-013-0320-4","volume":"17","author":"H Naitoh","year":"2014","unstructured":"Naitoh H, Yamamoto H, Murata S, Kobayashi H, Inoue K, Tani T. Stratified phase II trial to establish the usefulness of the collagen gel droplet embedded culture-drug sensitivity test (CD-DST) for advanced gastric cancer. Gastric Cancer. 2014;17:630\u20137.","journal-title":"Gastric Cancer"},{"key":"1842_CR11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.lungcan.2009.07.005","volume":"68","author":"M Higashiyama","year":"2010","unstructured":"Higashiyama M, Oda K, Okami J, Maeda J, Kodama K, Imamura F, et al. Prediction of chemotherapeutic effect on postoperative recurrence by in vitro anticancer drug sensitivity testing in non-small cell lung cancer patients. Lung Cancer. 2010;68:472\u20137.","journal-title":"Lung Cancer"},{"key":"1842_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00280-006-0292-8","volume":"59","author":"M Kawamura","year":"2007","unstructured":"Kawamura M, Gika M, Abiko T, Inoue Y, Oyama T, Izumi Y, et al. Clinical evaluation of chemosensitivity testing for patients with unresectable non-small cell lung cancer (NSCLC) using collagen gel droplet embedded culture drug sensitivity test (CD-DST). Cancer Chemother Pharmacol. 2007;59:507\u201313.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1842_CR13","first-page":"6045","volume":"14","author":"T Ochiai","year":"2017","unstructured":"Ochiai T, Nishimura K, Watanabe T, Kitajima M, Nakatani A, Nagayasu K, et al. Impact of the individualization of the first-line chemotherapy for advanced colorectal cancer based on collagen gel droplet-embedded drug sensitivity test. Oncol Lett. 2017;14:6045\u201352.","journal-title":"Oncol Lett"},{"key":"1842_CR14","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0140-6736(16)30583-9","volume":"388","author":"K Uesaka","year":"2016","unstructured":"Uesaka K, Boku N, Fukutomi A, Okamura Y, Konishi M, Matsumoto I, et al. Adjuvant chemotherapy of s-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). Lancet. 2016;388:248\u201357.","journal-title":"Lancet"},{"key":"1842_CR15","volume-title":"Classification of pancreatic carcinoma, 4th","author":"Japan Pancreas Society","year":"2017","unstructured":"Japan Pancreas Society. Classification of pancreatic carcinoma, 4th English ed. Tokyo: Kanehara & Co., Ltd.; 2017.","edition":"English"},{"key":"1842_CR16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s00535-018-1506-7","volume":"54","author":"F Motoi","year":"2019","unstructured":"Motoi F, Satoi S, Honda G, Wada K, Shinchi H, Matsumoto I, et al. A single-arm, phase ii trial of neoadjuvant gemcitabine and s1 in patients with resectable and borderline resectable pancreatic adenocarcinoma: Prep-01 study. J Gastroenterol. 2019;54:194\u2013203.","journal-title":"J Gastroenterol"},{"key":"1842_CR17","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s00534-013-0616-0","volume":"20","author":"S Satoi","year":"2013","unstructured":"Satoi S, Yamaue H, Kato K, Takahashi S, Hirono S, Takeda S, et al. Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci. 2013;20:590\u2013600.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"1842_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40792-017-0290-6","volume":"3","author":"K Ariake","year":"2017","unstructured":"Ariake K, Motoi F, Mizuma M, Murakami K, Takadate T, Ohtsuka H, et al. Locally advanced pancreatic cancer successfully treated by distal pancreatectomy with celiac axis resection (DP-CAR) after s-1 with radiation therapy followed by gemcitabine\/nab-paclitaxel therapy: a case report. Surg Case Rep. 2017;3:15.","journal-title":"Surg Case Rep"},{"key":"1842_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1080\/13651820601175918","volume":"9","author":"J Bai","year":"2007","unstructured":"Bai J, Sata N, Nagai H. Gene expression analysis for predicting gemcitabine sensitivity in pancreatic cancer patients. HPB (Oxford). 2007;9:150\u20135.","journal-title":"HPB (Oxford)"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-019-01842-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00595-019-01842-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-019-01842-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:26:01Z","timestamp":1593563161000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00595-019-01842-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,2]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1842"],"URL":"https:\/\/doi.org\/10.1007\/s00595-019-01842-5","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"type":"print","value":"0941-1291"},{"type":"electronic","value":"1436-2813"}],"subject":[],"published":{"date-parts":[[2019,7,2]]},"assertion":[{"value":"19 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"We have no conflicts of interest to disclose and we did not receive any financial support in relation to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}